Class I

Medical Device Recall: t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology

Tandem Diabetes Care, Inc. · March 5, 2024

Reason for Recall

During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.

Distribution

US nationwide distribution including Puerto Rico.

States Affected

NATIONWIDE

Quantity Affected

85,863 applications

Source: FDA (openFDA Device Enforcement)

Recall number: Z-1609-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Tandem Diabetes Care, Inc. Medical Device Recall: t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology | SafeCheck